Pulmonary rehabilitation provides you with the tools you need to manage your illness through lifestyle changes and coping techniques. These may include:

• Nutritional counseling
• Exercise training
• Stress management
• Breathing techniques
• Education about your disease and symptoms
• Mental health counseling and support

Your physician can discuss whether pulmonary rehabilitation is right for you and show you how to get set up with a program that is suited to your needs.

To know more, Consult Dr. Parthiv Shah, Pulmonologist in Mumbai - Call 9029772904

Dr Parthiv Shah, Pulmonologist in Mumbai

Hi! Fellow RT student here! I curious about what the pulmonary rehab outpatient is like.

For people working in this setting, what's your favorite part about working in this setting.

What are your dislikes? Thank you!

Full text of the article: A Randomized Controlled Pilot Study Using a Virtual Game System (VGS) as a Home-Based Exercise Modality Following Pulmonary Rehabilitation (PR) in Patients with COPD. Houssam Kotrach , Esther Dajczman , Marcel A. Baltzan , Rima Wardini , Suzanne Levitz , Michael Rotaple , Fredricka Abcarius , Maria Stathatos , Danielle Lynch , Norman Wolkove , Charles Sounan

American Thoracic Society 2016 International Conference, May 13-18, 2016 - San Francisco, Monday, May 16, B109. HIGHLIGHTS AND ADVANCES IN PULMONARY REHABILITATION

https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A4530

Introduced: Sponsor: Sen. Shelley Capito [R-WV]

This bill was referred to the Senate Committee on Finance which will consider it before sending it to the Senate floor for consideration.

Govtrack.us Summary

My father [74] has end stage COPD, completely bedridden, with less than 20% lung capacity. Sorry if I’m using the wrong terms. His pulmonologist suggested pulmonary rehab, that he needs exercise and movement to help otherwise he’s losing years of life. My area only has one pulmonary rehab available and it’s not good.

I was wondering if this is worth doing the effort to find it in other areas, possibly travel or move for it.

Thanks.

Hi all, I’ve been lurking here for a while as a person with COPD/Alpha-1 and I’ve seen so many queries from people regarding whether or not they have COPD or if their symptoms constitute COPD so I’ve decided to come up with a short synopsis from what I can see.

I’ll be speaking from a European perspective, but the broad strokes apply.

This is my perspective and does not constitute medical advice. My perspective does not take the place of your physician’s advice.

COPD is Chronic Obstructive Pulmonary Disease. It is characterised by 2 major conditions that can exist in isolation or in combination. They are; emphysema and chronic bronchitis. Emphysema is when the walls within the small air sacks (alveoli) in the lungs become damaged and break down due to chronic exposure to a toxic substance (smoke from any source for example). This reduces the amount of surface area your alveoli have and therefore impairs oxygen uptake and CO2 excretion. This is not a fast process, it occurs over years, even decades, not days to months really. Importantly it is a physical/structural diagnosis and can be seen on CT. Bronchitis on the other hand is a clinical diagnosis and is characterised a chronic cough caused by inflammation of the larger airways (left and right main bronchus [just beyond the trachea/windpipe]) in the lungs as far down as the bronchioles (the part of the lung just before the alveoli). COPD is characterised by chronic bronchitis, not acute bronchitis which is just another term for a cough/airway inflammation due to a chest infection. Outside of alpha-1 antitrypsin deficiency (see below), COPD is thought to occur in those who have a genetic susceptibility (multiple genes involved / polygenic) to toxins such as smoke exposure.

A point of clarification is that the emphysema component is not considered reversible and it is permanent damage, but chronic bronchitis may be somewhat reversible to some degree with therapies.

A second point of clarification is the terms obstructive pulmonary disease can be confusing as people confuse asthma, bronchiectasis and acute bronchitis with COPD. Obstructive pulmonary disease or obstructive lung disease is an umbrella term for conditions such as COPD, asthma, bronchiectasis, acute or chronic bronchitis etc. They are all different forms of obstructive lung diseases. **Asthma tends to affect younger people without smoke exposure and COPD tends to affect older people who have a significant amount of smoke e

last updated 9/29/21

Third shots continue to be available in Oregon, now for an expanded group. For the purposes of the discussion below, lets define the difference as:

3rd Dose-specifically for immunocompromised people as outlined below. Available to Moderna/Pfizer recipients.

Booster-for everyone else on the list (65+ population/workers in certain designations below). Only available to Pfizer recipients.There is no difference in the amount of vaccine you receive between the booster and third dose, nor is there a difference between the amount of vaccine you get for a third dose or a second of first. The amounts are always the same.

WHO IS ELIGIBLE

Third Dose-Immunocompromised individuals over 12 who received Moderna or Pfizer

• Cancer
• Chronic kidney disease
• Chronic lung diseases, including COPD (chronic obstructive pulmonary disease), asthma (moderate-to-severe), interstitial lung disease, cystic fibrosis, and pulmonary hypertension. These *may* include
  • Asthma, if it’s moderate to severe
  • Chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis
  • Having damaged or scarred lung tissue such as interstitial lung disease (including idiopathic pulmonary fibrosis)
  • Cystic fibrosis, with or without lung or other solid organ transplant
  • Pulmonary hypertension (high blood pressure in the lungs)
• Dementia or other neurological conditions
• Diabetes (type 1 or type 2)
• Down syndrome
• Heart conditions (such as heart failure, coronary artery disease, cardiomyopathies or hypertension)
• HIV infection
• Immunocompromised state (weakened immune system) - Prolonged use of corticosteroids or other immune weakening medicines can lead to secondary or acquired immunodeficiency.
• Liver disease
• Overweight and obesity (BMI) > 25 kg/m2
• Pregnancy
• Sickle cell disease or thalassemia
• Smoking, current or former
• Solid organ or blood stem cell transplant
• Stroke or cerebrovascular disease, which affects blood flow to the brain
• Substance use disorders

Booster- Anyone 65 or Older who received Pfizer

Booster- Anyone 18 or older who lives in one of these settings and received Pfizer

• Congregate care settings
• Long term care settings
• MultiFamily Housing
• People experiencing houselessness
• Any other setting where you are routinely exposed to people and at risk.
• Anyone affected by racial disparity, as defined by

Introduced: Sponsor: Sen. Michael Crapo [R-ID]

This bill was referred to the Senate Committee on Finance which will consider it before sending it to the Senate floor for consideration.

Sen. Michael Crapo [R-ID] is a member of the committee.

Govtrack.us Summary

Introduced: Sponsor: Sen. Charles Schumer [D-NY]

This bill is in the first stage of the legislative process. It was introduced into Congress on February 26, 2013. It will typically be considered by committee next.

Govtrack.us Summary